证券代码：603026 证券简称：石大胜华 公告编号：临 2025-030 石大胜华新材料集团股份有限公司 关于调整公司2022年度向特定对象发行A股股票方案 的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 石大胜华新材料集团股份有限公司（以下简称"公司"）于 2025 年 7 月 7 日召开第八届董事会第十七次会议、第八届监事会第十次会议，审议通过了《关 于调整公司 2022 年度向特定对象发行 A 股股票方案的议案》，现将相关事项公 告如下： 一、调整前的募集资金金额与用途 公司于 2024 年 9 月收到中国证券监督管理委员会（以下简称"中国证监会"） 出具的《关于同意石大胜华新材料集团股份有限公司向特定对象发行股票注册的 批复》（证监许可[2024]1288 号），同意公司 2022 年度向特定对象发行股票的 注册申请，根据《胜华新材2022年度向特定对象发行A股股票预案(三次修订稿)》， 本次向特定对象发行的股票数量不超过本次向特定对象发行前公司总股本的 30%，即不超过 60,804,000 股（含本 ...

（一）本次监事会会议的召开符合有关法律、行政法规、部门规章、规范性 文件和公司章程的规定。 （二）本次监事会会议于 2025 年 7 月 7 日以邮件、电话方式向公司监事会 全体监事发出第八届监事会第十次会议通知和材料。 （三）本次监事会会议于 2025 年 7 月 7 日以通讯表决方式在山东省东营市 垦利区同兴路 198 号石大胜华办公楼 A326 室召开。 证券代码：603026 证券简称：石大胜华 公告编号：临 2025-029 石大胜华新材料集团股份有限公司 第八届监事会第十次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、监事会会议召开情况 （一）通过《关于调整公司 2022 年度向特定对象发行 A 股股票方案的议案》。 经审核，监事会认为本次调整公司 2022 年度向特定对象发行 A 股股票方案 符合有关法律法规、规范性文件的规定，审议程序合法、合规，不存在损害公司 和全体股东特别是中小股东利益的情况。监事会同意根据股东会授权，募集资金 总额由不超过 199,000.00 万元（含本数）调整 ...

证券代码：603026 证券简称：石大胜华 公告编号：临 2025-028 石大胜华新材料集团股份有限公司 第八届董事会第十七次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、董事会会议召开情况 （一）本次董事会会议的召开符合有关法律、行政法规、部门规章、规范性 文件和公司章程的规定。 （二）本次董事会会议于 2025 年 7 月 7 日以邮件、电话方式向公司董事会 全体董事发出第八届董事会第十七次会议通知和材料。 （三）本次董事会会议于 2025 年 7 月 7 日以现场加通讯表决方式在山东省 东营市垦利区同兴路 198 号石大胜华办公楼 A325 室召开。 二、董事会会议审议情况 （一）通过《关于调整公司 2022 年度向特定对象发行 A 股股票方案的议案》。 根据公司股东会授予董事会办理与本次发行相关事宜的授权，公司本次向特 定对象发行股票调整了募集资金总额，调整后公司向特定对象发行股票募集资金 总额不超过 100,000 万元（含本数），除上述调整外，公司本次发行方案的其他 内容均保持不变。 该 ...

Group 1 - The company announced the adjustment of its 2022 A-share issuance plan, reducing the total fundraising amount from a maximum of 19.9 billion to 10 billion [1] - The net proceeds after deducting issuance costs are intended for various projects, including a 220,000 tons/year lithium battery materials R&D integration project (500 million), a 100,000 tons/year liquid lithium salt project (130 million), a 11,000 tons/year additive project (70 million), and to supplement working capital (300 million) [1] - Other aspects of the plan remain unchanged [1]

Core Viewpoint - The article discusses the challenges faced by the lithium battery electrolyte industry, particularly focusing on the financial performance of Shida Shenghua, which is experiencing significant losses due to market conditions and operational issues [1][4][5]. Group 1: Company Performance - Shida Shenghua expects a net loss of 52 million to 60 million yuan for the first half of 2025, a decrease of 90.06 million to 98.06 million yuan compared to the same period last year, representing a year-on-year decline of 236.64% to 257.66% [1][3]. - The company has seen a continuous decline in net profit over the past three years, with year-on-year decreases of 24.42%, 97.90%, and 12.32% from 2022 to 2024, with 2024's net profit only being 18.44% of 2022's [4][5]. Group 2: Market Conditions - The electrolyte market has been facing a downturn, with average sales prices for ternary electrolytes dropping from 30,000 yuan per ton at the beginning of 2024 to a low of 23,000 yuan per ton, and lithium iron phosphate electrolytes from 22,000 yuan per ton to 20,000 yuan per ton [4]. - The average price of various electrolytes is currently below 20,000 yuan per ton, marking a low point for the past three years [4]. Group 3: Operational Challenges - Shida Shenghua's production facilities in Wuhan are still in the customer introduction phase, leading to lower output and higher fixed costs, which have negatively impacted the company's net profit [3][7]. - The company has a total production capacity of 300,000 tons of electrolytes in Dongying and 200,000 tons in Wuhan, with the Dongying facility operating stably while the Wuhan facility is expected to start production in mid-2024 [7]. Group 4: Strategic Partnerships - Shida Shenghua has signed a strategic cooperation framework agreement with CATL, expecting to supply 100,000 tons of electrolytes, which could positively impact the company's performance if fully executed [7][8]. Group 5: Industry Outlook - The electrolyte sector is anticipated to enter a critical phase of capacity clearing between 2025 and 2027, with an expected improvement in supply-demand dynamics as outdated capacities exit the market [8]. - Companies in the sector need to manage costs effectively and innovate product technologies to maintain competitiveness during market fluctuations [8].

Core Viewpoint - The company, Shida Shenghua (603026.SH), announced multiple updates including personnel changes, a profit warning for the first half of 2025, and an extension of the validity period for its A-share issuance plan to specific investors [1][2][6]. Group 1: A-Share Issuance Plan - The board of directors approved a 12-month extension for the validity period of the 2022 A-share issuance plan, which requires shareholder approval [2][4]. - The initial plan aimed to raise up to 4.5 billion yuan for seven projects, including a 500,000-ton electrolyte production facility [4][5]. - The plan faced multiple delays and revisions, with the fundraising amount reduced to 1.99 billion yuan and the cancellation of the electrolyte projects due to feasibility concerns [5]. Group 2: Financial Performance - The company expects a net loss of 52 million to 60 million yuan for the first half of 2025, a significant decrease compared to the previous year [6]. - Revenue and net profit have declined for three consecutive years, with revenues of 8.316 billion yuan, 5.635 billion yuan, and 5.547 billion yuan from 2022 to 2024, reflecting year-on-year changes of -17.86%, -32.24%, and -1.56% respectively [10]. - The main business areas include electrolytes, carbonates, and methyl tert-butyl ether, all of which are currently facing challenges such as overcapacity and declining prices [10]. Group 3: Strategic Partnerships - The company has established a strategic cooperation agreement with CATL, a leading lithium-ion battery manufacturer, to supply an estimated 100,000 tons of electrolyte by December 31, 2025 [10][11]. - This partnership is expected to positively impact the company's operational performance and enhance its market position in the lithium battery materials sector [11].

Core Viewpoint - The company Shida Shenghua is facing significant financial pressure in the first half of 2025, with expected net losses due to product price fluctuations and high costs associated with new facilities [1][2]. Financial Performance - Shida Shenghua anticipates a net profit loss of between 52 million to 60 million yuan for the first half of 2025, a decrease of 90.06 million to 98.06 million yuan compared to the same period last year, representing a year-on-year decline of 236.64% to 257.66% [1]. - The company also expects a loss in its net profit excluding non-recurring items of 53 million to 61 million yuan, down by 84.37 million to 92.37 million yuan from the previous year, reflecting a decline of 268.93% to 294.43% [1]. - This marks the third consecutive year of declining net profit and net profit excluding non-recurring items since 2022 [2]. Revenue Trends - Shida Shenghua's revenue figures for the years 2022 to 2024 were 8.316 billion yuan, 5.635 billion yuan, and 5.547 billion yuan, with year-on-year changes of 17.86%, -32.24%, and -1.56% respectively [2]. - The net profit for the same years was 891 million yuan, 18.726 million yuan, and 16.4196 million yuan, showing declines of 24.42%, 97.9%, and 12.32% respectively [2]. - The net profit excluding non-recurring items was 857 million yuan, 13.2343 million yuan, and 5.3878 million yuan, with declines of 26.4%, 98.46%, and 59.29% respectively [2]. Business Operations - The company has transitioned from traditional chemical operations to focus on new energy and new materials, including sectors such as electrolyte, carbonate, and methyl tert-butyl ether [2]. - The production at the Wuhan base for electrolyte is currently in the customer introduction phase, leading to underproduction and high fixed costs [3]. - The decline in profits is also attributed to falling prices of methyl tert-butyl ether products and lithium fluoride raw materials [3]. Regulatory Issues - Shida Shenghua received an administrative regulatory decision due to issues in insider information management, leading to corrective measures and warnings issued to key executives [4].

Industry Overview - The lithium battery industry is currently at the bottom of its cycle, but the demand for components like electrolytes remains uncertain, leading to ongoing operational pressures for manufacturers in the second half of the year [1][6] - The average price of various electrolytes in China is below 20,000 yuan per ton, marking a near three-year low [1][2] Company Performance - Shida Shenghua (603026.SH) is expected to report a net profit loss of 52 million to 60 million yuan for the first half of the year, with a year-on-year decrease in net profit of 236.64% to 257.66% [1][2] - The company reported a net profit loss of approximately 3.15 million yuan in the second quarter, following a loss of 28.54 million yuan in the first quarter [2] Factors Affecting Profitability - The loss is attributed to three main factors: high fixed costs due to underproduction at the Wuhan facility, declining prices of methyl tert-butyl ether products, and falling prices of lithium fluoride and its raw material lithium carbonate [2][4] - The company's gross margin has significantly decreased from 31.5% in 2021 to below 6% in 2024, with a sales gross margin of only 5.6% and a net profit margin of -3.42% as of the first quarter [5] Market Dynamics - The electrolyte market is characterized by a supply-demand imbalance, with low operating rates and a concentration of orders among leading companies, while smaller firms face reduced orders or even shutdowns [3][6] - The price of electrolytes is expected to remain under pressure, with projections indicating a price range of 16,000 to 20,000 yuan per ton in the second half of the year [6] Future Outlook - The potential for price recovery in the electrolyte market is limited, with weak cost support from key raw materials like lithium hexafluorophosphate [5][6] - The industry may see some demand growth in the second half, but significant improvements are uncertain unless there is an unexpected surge in demand [6]

Group 1 - Shida Shenghua expects a net loss of 52 million to 60 million yuan for the first half of 2025, a year-on-year decrease of 236.64% to 257.66% [1] - ST Zhizhi's vice president Wang Dong resigned for personal reasons, effective immediately upon delivery of the resignation to the board [1] - Haoyuan Pharmaceutical plans to increase capital by 400 million yuan to its wholly-owned subsidiary through a debt-to-equity swap, raising the registered capital from 400 million to 800 million yuan [1] Group 2 - Longxun Co. announced that shareholders and executives plan to reduce their holdings by up to 2% of the company's shares [2] - Aijian Group confirmed it has not engaged in any stablecoin-related business as of now [3] - Yanghe Co.'s chairman Zhang Liandong resigned due to work adjustments, effective immediately [5] Group 3 - Huanwei New Materials announced a stock suspension due to the major matter that may lead to a change in control [5] - Hualing Cable recently won contracts worth 456 million yuan in the power new energy sector, accounting for 10.97% of its audited revenue for 2024 [6] - Aerospace Changfeng plans to publicly transfer 55.45% of its stake in Aerospace Boke [6] Group 4 - Suzhou Planning is planning to acquire control of Dongjin Aerospace Technology, leading to a stock suspension for up to 10 trading days [6] - Yuexiu Capital intends to increase its stake in Yuexiu Real Estate using up to 204.22 million yuan through the Hong Kong Stock Connect [6] - Baichuan Co.'s actual controller and chairman Zheng Tiejiang is under investigation and has received a detention notice [7] Group 5 - XWANDA plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange [8] - ST Aowei reported a loss of approximately 25.04 million yuan in inventory due to poor storage by a third party [8] - Yian Technology plans to increase capital by 120 million yuan to its subsidiary, raising its equity stake from 60% to 72.973% [9] Group 6 - Dongli New Science's wholly-owned subsidiary was applied for bankruptcy reorganization by creditors due to insolvency [11] - Bochuang Technology changed its name to Changxin Bochuang Technology, effective July 2, 2025 [14] - Huayang Co.'s controlling shareholder received a notice of administrative penalty from the China Securities Regulatory Commission [15] Group 7 - Hangzhou Thermal Power's shareholders plan to reduce their holdings by up to 4.09% of the company's shares [16] - Guoke Military Industry's two shareholders plan to reduce their holdings by up to 1.81% of the company's shares [17] - Pangu Intelligent's seven shareholders plan to reduce their holdings by up to 1% of the company's shares [19]

Core Viewpoint - The A-share companies have accelerated the disclosure of mid-term performance forecasts, with 8 companies announcing their forecasts this week, indicating a positive trend in profitability for most companies [1][4]. Group 1: Company Performance Forecasts - Among the 8 companies that disclosed their mid-term forecasts, 7 expect to report profits while 1 anticipates a loss [1]. - Han Yu Pharmaceutical is projected to achieve a net profit of 142 million to 162 million yuan, representing a year-on-year growth of 1470.82% to 1663.89%, the highest growth rate among the companies [1][3]. - Xinhecheng forecasts a net profit of 330 million to 375 million yuan, with a year-on-year increase of 50% to 70% [2][3]. - Guomai Technology expects a net profit of 12.5 million to 15.6 million yuan, with a year-on-year growth of 60.52% to 100.33% [2]. - Weichai Heavy Machine anticipates a net profit of 13.18 million to 15.06 million yuan, with a year-on-year increase of 40% to 60% [2]. - The only company forecasting a loss is Shida Shenghua, expecting a loss of 52 million to 60 million yuan, a decline of 236.64% to 257.66% year-on-year [2][3]. Group 2: Industry Insights - Han Yu Pharmaceutical's revenue is primarily driven by international business, benefiting from global market demand, approval of its product by the FDA, and effective cost control [3]. - Xinhecheng, a leader in the vitamin industry, reported growth in sales volume and prices of its main products in the nutrition segment, contributing to its improved performance [3]. - The overall trend in the A-share market shows that out of 29 companies that have released mid-term forecasts, 27 expect profits and 2 anticipate losses, with 23 companies projecting year-on-year profit growth [4].